You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 46 No. 4, April 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  OBSERVATIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Myasthenic Syndrome Caused by Direct Effect of Chloroquine on Neuromuscular Junction

Wim Robberecht, MD; Joseph Bednarik, MD; Paul Bourgeois, MD; Johan van Hees, MD; Herwig Carton, MD

Arch Neurol. 1989;46(4):464-468.


Abstract

• Chloroquine induced a myasthenic syndrome in a patient taking the drug for presumable reticular erythematous mucinosis. Clinical features and results of single-fiber electromyography were typical for a failure of neuromuscular transmission, while peripheral nerves and muscles were intact on clinical, biochemical, electrophysiologic, and pathologic investigation. The time course of the clinical and electrophysiologic findings during provocation with chloroquine and the absence of autoantibodies indicate that the syndrome was due to a direct effect of the drug on the neuromuscular junction. While not taking chloroquine, the patient showed a decremental response on a modified double-step nerve stimulation test and a mean consecutive difference on single-fiber electromyography that was at the upper limit of normal, indicating a subclinical impairment of neuromuscular transmission. These findings can explain the apparent rarity of the syndrome described, as a direct effect of chloroquine on the neuromuscular junction may only have clinical relevance in patients with a reduced neuromuscular safety factor.



Author Affiliations

From the Departments of Neurology (Drs Robberecht, Bourgeois, van Hees, and Carton), University Hospital Leuven (Belgium), and Purkyne University, Brno, Czechoslovakia (Dr Bednarik).


Footnotes

Accepted for publication March 21, 1988.

Reprint requests to Department of Neurology, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium (Dr Carton).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Third cranial nerve palsy or pseudo 3rd nerve palsy of myasthenia gravis? A challenging diagnosis in systemic lupus erythematosus
Appenzeller et al.
Lupus 2009;18:836-840.
ABSTRACT  

Primary hyperthyroidism due to a parathyroid adenoma with subsequent myasthenia gravis
Palin and Singh
QJM 2000;93:560-561.
FULL TEXT  

Drugs and Myasthenia Gravis: An Update
Wittbrodt
Arch Intern Med 1997;157:399-408.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.